By Ludwig Burger and Ariane Luthi (Reuters) -Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a ...

The pharmaceutical giant said it has agreed to acquire the U.S. privately held, clinical-stage biopharmaceutical company to ...

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...

Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of ...

Blackstone beat estimates for fourth-quarter profit on Thursday, driven by a pickup in dealmaking, while executives at the ...

Net income for the quarter totaled $1.3 billion, or $0.92 per share, in a 1,120% increase from $109 million a year earlier.

Hans-Holger Albrecht, Chairman of Superbet Group, noted the confidence that Blackstone and HPS have placed in the company’s ...

Blackstone’s approach to board construction ensures a mix of experts and independent directors. It also builds the C-suite ...

Blackstone said on Thursday its massive investments in data centers would not be undermined by the low-cost artificial ...

Blackstone, a major global investor in data centers that run A.I. systems, expects use of the technology to rise as the cost ...

she has spent the last four years refining Blackstone’s CEO recruitment framework for its 250 portfolio companies, developing a meticulously structured and thorough executive hiring process that ...

Blackstone Mortgage Trust (NYSE:BXMT – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Wednesday, February 12th. Analysts expect the company to announce ...